Protein | Taxonomy | sb 203580 (IC50) | staurosporine (IC50) |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0558 |
Chain A, Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.012 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain X, Proto-oncogene tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0048 |
Chain A, Serine/threonine-protein kinase TAO2 | Rattus norvegicus (Norway rat) | | 3 |
epidermal growth factor receptor isoform a precursor | Homo sapiens (human) | | 0.4467 |
Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | | 0.01 |
Cell division cycle 7-related protein kinase | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | | 0.0083 |
Serine/threonine-protein kinase 25 | Homo sapiens (human) | | 0.0029 |
Citron Rho-interacting kinase | Homo sapiens (human) | | 0.749 |
Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | | 0.9255 |
Telomerase reverse transcriptase | Homo sapiens (human) | | 6.9517 |
Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | | 0.1772 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | | 0.5561 |
Aurora kinase A | Homo sapiens (human) | | 0.0087 |
Cyclin-G-associated kinase | Homo sapiens (human) | | 0.011 |
Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | | 0.267 |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | | 0.1265 |
Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | | 0.1161 |
Mitogen-activated protein kinase 13 | Homo sapiens (human) | | 0.4137 |
3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | | 0.0072 |
Death-associated protein kinase 3 | Homo sapiens (human) | | 0.0026 |
Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | | 0.0565 |
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.356 |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | | 0.0231 |
NUAK family SNF1-like kinase 1 | Homo sapiens (human) | | 0.003 |
Cyclin-T1 | Homo sapiens (human) | | 0.0118 |
Cyclin-T2 | Homo sapiens (human) | | 0.0038 |
Tyrosine-protein kinase JAK2 | Homo sapiens (human) | | 0.0016 |
Rho-associated protein kinase 2 | Homo sapiens (human) | | 0.0045 |
Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | | 0.0096 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | | 0.1246 |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | | 0.0011 |
Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | | 0.0071 |
Serine/threonine-protein kinase 16 | Homo sapiens (human) | | 0.2385 |
Cyclin-K | Homo sapiens (human) | | 0.0948 |
Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase 17B | Homo sapiens (human) | | 0.0258 |
Serine/threonine-protein kinase 10 | Homo sapiens (human) | | 0.008 |
Serine/threonine-protein kinase D3 | Homo sapiens (human) | | 0.1446 |
Cyclin-dependent kinase 14 | Homo sapiens (human) | | 0.1145 |
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | | 0.0107 |
Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | | 0.2829 |
Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | | 0.013 |
Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | | 0.0132 |
Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | | 0.0212 |
G1/S-specific cyclin-E2 | Homo sapiens (human) | | 0.011 |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | | 0.0812 |
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | | 0.1233 |
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | | 0.0063 |
Epidermal growth factor receptor | Homo sapiens (human) | | 0.083 |
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | | 0.1281 |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | | 0.0713 |
High affinity nerve growth factor receptor | Homo sapiens (human) | | 0.2403 |
Protein kinase C gamma type | Homo sapiens (human) | | 0.1167 |
Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | | 0.002 |
Protein kinase C alpha type | Rattus norvegicus (Norway rat) | | 0.2327 |
Protein kinase C beta type | Homo sapiens (human) | | 0.0684 |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | | 0.056 |
Insulin receptor | Homo sapiens (human) | | 0.0706 |
Tyrosine-protein kinase Lck | Homo sapiens (human) | | 0.1784 |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0929 |
Retinoblastoma-associated protein | Homo sapiens (human) | | 0.066 |
Cyclin-dependent kinase 1 | Homo sapiens (human) | | 0.0075 |
Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | | 0.0039 |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | | 0.1269 |
Tyrosine-protein kinase Yes | Homo sapiens (human) | | 0.0029 |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0012 |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | | 0.0021 |
Insulin-like growth factor 1 receptor | Homo sapiens (human) | | 0.5534 |
Hepatocyte growth factor receptor | Homo sapiens (human) | | 0.1917 |
Tyrosine-protein kinase HCK | Homo sapiens (human) | | 0.0025 |
Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | | 0.0004 |
Protein kinase C delta type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C zeta type | Rattus norvegicus (Norway rat) | | 0.274 |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | | 0.3707 |
Tyrosine-protein kinase Fgr | Homo sapiens (human) | | 0.0009 |
Cytochrome P450 2D6 | Homo sapiens (human) | | 0.0002 |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | | 0.0412 |
Breakpoint cluster region protein | Homo sapiens (human) | | 0.0945 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | | 0.059 |
Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | | 0.0216 |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | | 0.0699 |
Cyclin-dependent kinase 1 | Mus musculus (house mouse) | | 0.008 |
Cyclin-dependent kinase 4 | Homo sapiens (human) | | 0.0429 |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | | 0.3642 |
Acyl-CoA desaturase 1 | Mus musculus (house mouse) | | 3.4 |
Insulin receptor-related protein | Homo sapiens (human) | | 0.0113 |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | | 0.0088 |
Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | | 0.003 |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | | 4 |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | | 0.0107 |
Insulin receptor | Mus musculus (house mouse) | | 0.2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | | 0.0004 |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase Fer | Homo sapiens (human) | | 0.0008 |
Protein kinase C alpha type | Homo sapiens (human) | | 0.0655 |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | | 0.0115 |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | | 0.0149 |
Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | | 0.011 |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | | 0.1 |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | | 0.0025 |
Casein kinase II subunit alpha' | Homo sapiens (human) | | 2.0215 |
Cyclin-A2 | Homo sapiens (human) | | 0.009 |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | | 0.01 |
Serine/threonine-protein kinase MAK | Homo sapiens (human) | | 0.0257 |
Ephrin type-A receptor 1 | Homo sapiens (human) | | 0.0947 |
Fibroblast growth factor receptor 2 | Homo sapiens (human) | | 0.0504 |
Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | | 0.0106 |
Fibroblast growth factor receptor 4 | Homo sapiens (human) | | 0.17 |
Fibroblast growth factor receptor 3 | Homo sapiens (human) | | 0.0554 |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | | 0.0137 |
Cyclin-O | Homo sapiens (human) | | 0.0015 |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | | 0.0148 |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase JAK1 | Homo sapiens (human) | | 0.004 |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | | 0.028 |
G1/S-specific cyclin-D1 | Homo sapiens (human) | | 0.0355 |
Protein kinase C eta type | Homo sapiens (human) | | 0.1165 |
Cyclin-C | Homo sapiens (human) | | 0.0105 |
G1/S-specific cyclin-E1 | Homo sapiens (human) | | 0.0108 |
Cyclin-dependent kinase 2 | Homo sapiens (human) | | 0.0073 |
Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | | 1.1595 |
Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | | 0.002 |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | | 4.6724 |
MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | | 0.0004 |
cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | | 0.055 |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | | 2.6853 |
Ephrin type-A receptor 2 | Homo sapiens (human) | | 0.1257 |
Ephrin type-A receptor 3 | Homo sapiens (human) | | 0.0347 |
Ephrin type-A receptor 8 | Homo sapiens (human) | | 0.1061 |
Ephrin type-B receptor 2 | Homo sapiens (human) | | 0.1191 |
Leukocyte tyrosine kinase receptor | Homo sapiens (human) | | 0.0173 |
Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | | 0.0137 |
G1/S-specific cyclin-D3 | Homo sapiens (human) | | 0.055 |
Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | | 0.0131 |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | | 0.1848 |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | | 0.4119 |
G protein-coupled receptor kinase 4 | Homo sapiens (human) | | 0.0914 |
Kinesin-1 heavy chain | Homo sapiens (human) | | 0.0015 |
G protein-coupled receptor kinase 5 | Homo sapiens (human) | | 0.0489 |
Hexokinase-4 | Homo sapiens (human) | | 0.0006 |
Beta-adrenergic receptor kinase 2 | Homo sapiens (human) | | 0.856 |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | | 0.0146 |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | | 0.1791 |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | | 0.026 |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | | 0.0014 |
Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | | 4.288 |
Activin receptor type-1B | Homo sapiens (human) | | 9.118 |
TGF-beta receptor type-1 | Homo sapiens (human) | | 2.2823 |
Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | | 0.85 |
Tyrosine-protein kinase CSK | Homo sapiens (human) | | 0.2071 |
Protein kinase C iota type | Homo sapiens (human) | | 0.1739 |
Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | | 0.442 |
Tyrosine-protein kinase Tec | Homo sapiens (human) | | 0.0338 |
Tyrosine-protein kinase TXK | Homo sapiens (human) | | 0.0203 |
Tyrosine-protein kinase ABL2 | Homo sapiens (human) | | 0.0505 |
Tyrosine-protein kinase FRK | Homo sapiens (human) | | 0.0108 |
G protein-coupled receptor kinase 6 | Homo sapiens (human) | | 0.0473 |
Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0175 |
Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.0057 |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | | 1.1067 |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | | 2.0555 |
Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | | 0.863 |
Phosphorylase b kinase regulatory subunit alpha, liver isoform | Homo sapiens (human) | | 0.0005 |
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Homo sapiens (human) | | 0.0005 |
Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | | 0.0099 |
Casein kinase I isoform alpha | Homo sapiens (human) | | 3.412 |
Casein kinase I isoform delta | Homo sapiens (human) | | 1.4 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | | 9 |
MAP kinase-activated protein kinase 2 | Homo sapiens (human) | | 0.735 |
Cyclin-dependent kinase 8 | Homo sapiens (human) | | 0.0105 |
Casein kinase I isoform epsilon | Homo sapiens (human) | | 1.4 |
Dual specificity protein kinase CLK1 | Homo sapiens (human) | | 0.0108 |
Dual specificity protein kinase CLK2 | Homo sapiens (human) | | 0.6508 |
Dual specificity protein kinase CLK3 | Homo sapiens (human) | | 0.92 |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | | 0.0103 |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | | 0.0435 |
D(1A) dopamine receptor | Sus scrofa (pig) | | 0.001 |
Cyclin-dependent kinase 7 | Homo sapiens (human) | | 0.2793 |
Cyclin-dependent kinase 9 | Homo sapiens (human) | | 0.0474 |
Tyrosine-protein kinase Blk | Homo sapiens (human) | | 0.0011 |
Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | | 0.0377 |
Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | | 0.0002 |
Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | | 0.0046 |
cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | | 0.0014 |
Cyclin-H | Homo sapiens (human) | | 0.2793 |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | | 0.1216 |
Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | | 1.7683 |
Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | | 0.0851 |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | | 0.0084 |
Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | | 0.0036 |
Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | | 0.4397 |
Death-associated protein kinase 1 | Homo sapiens (human) | | 0.0101 |
LIM domain kinase 1 | Homo sapiens (human) | | 0.0026 |
LIM domain kinase 2 | Homo sapiens (human) | | 0.0956 |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | | 0.4512 |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | | 0.0731 |
5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | | 1.1354 |
Ephrin type-B receptor 3 | Homo sapiens (human) | | 1.2855 |
Ephrin type-A receptor 5 | Homo sapiens (human) | | 0.0159 |
Ephrin type-B receptor 4 | Homo sapiens (human) | | 0.1869 |
Ephrin type-B receptor 1 | Homo sapiens (human) | | 0.0694 |
Ephrin type-A receptor 4 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | | 0.0009 |
Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | | 0.24 |
Protein kinase C gamma type | Rattus norvegicus (Norway rat) | | 0.2168 |
Casein kinase II subunit beta | Homo sapiens (human) | | 3.4 |
Casein kinase II subunit alpha | Homo sapiens (human) | | 3.4723 |
Protein kinase C beta type | Rattus norvegicus (Norway rat) | | 0.2029 |
SRSF protein kinase 2 | Homo sapiens (human) | | 0.206 |
Casein kinase I isoform gamma-2 | Homo sapiens (human) | | 1.9467 |
Cyclin-A1 | Homo sapiens (human) | | 0.0013 |
Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | | 0.0044 |
MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | | 4 |
Cyclin-dependent kinase 3 | Homo sapiens (human) | | 0.0118 |
Cyclin-dependent kinase 6 | Homo sapiens (human) | | 0.0395 |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | | 0.0141 |
Cyclin-dependent kinase 16 | Homo sapiens (human) | | 0.0206 |
Cyclin-dependent kinase 17 | Homo sapiens (human) | | 0.0135 |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | | 0.048 |
Protein kinase C epsilon type | Homo sapiens (human) | | 0.0767 |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | | 0.2314 |
Angiopoietin-1 receptor | Homo sapiens (human) | | 0.0823 |
Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | | 0.1952 |
Protein kinase C theta type | Homo sapiens (human) | | 0.1168 |
Activin receptor type-1 | Homo sapiens (human) | | 1.1354 |
Macrophage-stimulating protein receptor | Homo sapiens (human) | | 0.2195 |
Focal adhesion kinase 1 | Homo sapiens (human) | | 0.078 |
Protein kinase C zeta type | Homo sapiens (human) | | 0.1722 |
Protein kinase C delta type | Homo sapiens (human) | | 0.1283 |
Tyrosine-protein kinase BTK | Homo sapiens (human) | | 0.0288 |
Aldehyde oxidase | Homo sapiens (human) | | 0.0023 |
Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | | 0.0177 |
Cyclin-dependent kinase 18 | Homo sapiens (human) | | 0.0587 |
Activated CDC42 kinase 1 | Homo sapiens (human) | | 0.0299 |
Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | | 0.9655 |
Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | | 0.0068 |
Myotonin-protein kinase | Homo sapiens (human) | | 0.1735 |
Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | | 0.0992 |
Tyrosine-protein kinase Mer | Homo sapiens (human) | | 0.0331 |
Serine/threonine-protein kinase 4 | Homo sapiens (human) | | 0.0013 |
Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | | 0.0004 |
Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | | 0.0252 |
Mitogen-activated protein kinase 7 | Homo sapiens (human) | | 4.0032 |
Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | | 0.0021 |
Serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0034 |
Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | | 0.438 |
cGMP-dependent protein kinase 2 | Homo sapiens (human) | | 0.0161 |
Rho-associated protein kinase 1 | Homo sapiens (human) | | 0.0038 |
Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | | 0.0012 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | | 0.0018 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | | 0.0026 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | | 0.0024 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | | 0.0095 |
Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | | 1.94 |
Protein-tyrosine kinase 6 | Homo sapiens (human) | | 0.484 |
cGMP-dependent protein kinase 1 | Homo sapiens (human) | | 0.0027 |
Cyclin-dependent kinase 13 | Homo sapiens (human) | | 0.057 |
Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | | 0.0032 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | | 0.0003 |
Protein-tyrosine kinase 2-beta | Homo sapiens (human) | | 0.0095 |
Maternal embryonic leucine zipper kinase | Homo sapiens (human) | | 0.0006 |
Lysine--tRNA ligase | Homo sapiens (human) | | 0.0049 |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | | 0.0141 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase D1 | Homo sapiens (human) | | 0.1448 |
Serine/threonine-protein kinase 38 | Homo sapiens (human) | | 0.0037 |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | | 0.183 |
Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | | 0.0002 |
Ephrin type-A receptor 7 | Homo sapiens (human) | | 0.0477 |
Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0004 |
Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | | 0.1995 |
Myosin light chain kinase, smooth muscle | Homo sapiens (human) | | 0.0448 |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | | 0.037 |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | | 1 |
Serine/threonine-protein kinase STK11 | Homo sapiens (human) | | 0.0598 |
Rhodopsin kinase GRK1 | Homo sapiens (human) | | 0.068 |
Coiled-coil domain-containing protein 6 | Homo sapiens (human) | | 0.0022 |
NT-3 growth factor receptor | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase N1 | Homo sapiens (human) | | 0.0025 |
Serine/threonine-protein kinase N2 | Homo sapiens (human) | | 0.0055 |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | | 0.5052 |
Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | | 0.1475 |
Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | | 0.016 |
BDNF/NT-3 growth factors receptor | Homo sapiens (human) | | 0.0004 |
MAP kinase-activated protein kinase 3 | Homo sapiens (human) | | 2.775 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | | 0.0017 |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | | 0.0008 |
Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | | 0.0432 |
Rho-associated protein kinase 2 | Bos taurus (cattle) | | 0.0417 |
Myosin light chain kinase 3 | Homo sapiens (human) | | 0.1585 |
Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | | 0.1464 |
Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | | 0.0087 |
Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0077 |
Mitogen-activated protein kinase kinase kinase 21 | Homo sapiens (human) | | 1.1175 |
Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | | 0.0032 |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | | 0.0067 |
Testis-specific serine/threonine-protein kinase 1 | Mus musculus (house mouse) | | 0.0003 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | | 0.012 |
Protein kinase C eta type | Rattus norvegicus (Norway rat) | | 0.274 |
Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | | 0.0005 |
Calcium/calmodulin-dependent protein kinase type 1B | Homo sapiens (human) | | 0.0044 |
Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | | 0.0864 |
Serine/threonine-protein kinase N3 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | | 0.0027 |
Kinase suppressor of Ras 2 | Homo sapiens (human) | | 5.4 |
Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | | 0.0552 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | | 0.0416 |
Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | | 0.0001 |
Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | | 0.0008 |
Serine/threonine-protein kinase Nek8 | Homo sapiens (human) | | 0.0263 |
Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | | 0.0035 |
Serine/threonine-protein kinase 32C | Homo sapiens (human) | | 0.232 |
Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | | 0.0001 |
Myosin light chain kinase family member 4 | Homo sapiens (human) | | 0.0537 |
Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | | 2.639 |
Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | | 0.0003 |
Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | | 0.0001 |
Kinase suppressor of Ras 1 | Homo sapiens (human) | | 6.265 |
Cyclin-dependent kinase-like 3 | Homo sapiens (human) | | 1.1 |
MAP kinase-activated protein kinase 5 | Homo sapiens (human) | | 0.212 |
Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | | 0.0028 |
Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | | 0.1102 |
Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | | 0.0032 |
Misshapen-like kinase 1 | Homo sapiens (human) | | 0.0004 |
Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | | 0.089 |
Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | | 0.0359 |
Casein kinase I isoform alpha-like | Homo sapiens (human) | | 1.84 |
Cyclin-Y | Homo sapiens (human) | | 0.0518 |
Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | | 0.226 |
Myosin-IIIa | Homo sapiens (human) | | 0.0425 |
Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | | 0.521 |
Protein odd-skipped-related 1 | Homo sapiens (human) | | 0.0402 |
Mitogen-activated protein kinase 15 | Homo sapiens (human) | | 0.0081 |
Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | | 0.101 |
Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | | 0.0007 |
Serine/threonine-protein kinase haspin | Homo sapiens (human) | | 0.0422 |
Rhodopsin kinase GRK7 | Homo sapiens (human) | | 0.0053 |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | | 0.0107 |
Myosin-IIIb | Homo sapiens (human) | | 0.0058 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | | 0.18 |
Phosphorylase b kinase regulatory subunit beta | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | | 0.073 |
Aurora kinase B | Homo sapiens (human) | | 0.007 |
Lymphokine-activated killer T-cell-originated protein kinase | Homo sapiens (human) | | 0.0691 |
MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | | 0.0001 |
Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | | 0.0047 |
Testis-specific serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0038 |
Testis-specific serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0051 |
Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | | 0.0122 |
PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | | 0.0107 |
Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | | 0.0246 |
SRSF protein kinase 1 | Homo sapiens (human) | | 0.0337 |
Mitogen-activated protein kinase kinase kinase 14 | Homo sapiens (human) | | 2.3 |
Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | | 0.215 |
Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | | 0.0092 |
MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | | 0.0531 |
Testis-specific serine/threonine-protein kinase 6 | Homo sapiens (human) | | 0.1525 |
Serine/threonine-protein kinase 33 | Homo sapiens (human) | | 0.0374 |
Serine/threonine-protein kinase D2 | Homo sapiens (human) | | 0.0014 |
NUAK family SNF1-like kinase 2 | Homo sapiens (human) | | 0.0018 |
Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | | 0.3669 |
Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | | 0.0147 |
STE20-like serine/threonine-protein kinase | Homo sapiens (human) | | 0.0142 |
Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | | 0.0017 |
Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | | 0.3655 |
Tyrosine-protein kinase Srms | Homo sapiens (human) | | 6.5 |
Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | | 0.456 |
Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | | 0.203 |
Inactive tyrosine-protein kinase PEAK1 | Homo sapiens (human) | | 0.0025 |
Dual specificity protein kinase CLK4 | Homo sapiens (human) | | 0.0723 |
MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0221 |
Serine/threonine-protein kinase Sgk2 | Homo sapiens (human) | | 0.0159 |
Casein kinase I isoform gamma-1 | Homo sapiens (human) | | 5.3367 |
NADPH oxidase 4 | Homo sapiens (human) | | 0.0708 |
Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | | 0.0327 |
SNF-related serine/threonine-protein kinase | Homo sapiens (human) | | 0.0059 |
Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | | 0.0062 |
Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | | 0.0122 |
Serine/threonine-protein kinase 32B | Homo sapiens (human) | | 0.0375 |
Cyclin-dependent kinase 12 | Homo sapiens (human) | | 0.053 |
Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | | 0.546 |
Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | | 0.0813 |
Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | | 0.0039 |
Serine/threonine-protein kinase 26 | Homo sapiens (human) | | 0.0124 |
Serine/threonine-protein kinase NLK | Homo sapiens (human) | | 0.0666 |
Ribosomal protein S6 kinase beta-2 | Homo sapiens (human) | | 0.0015 |
Protein DBF4 homolog A | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase 17A | Homo sapiens (human) | | 0.0386 |
STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | | 0.0158 |
Ephrin type-A receptor 6 | Homo sapiens (human) | | 0.0161 |
Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | | 0.003 |
Death-associated protein kinase 2 | Homo sapiens (human) | | 0.0064 |
Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | | 0.0001 |
TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | | 0.0103 |
Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | | 0.0295 |
Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | | 0.0076 |
ALK tyrosine kinase receptor | Homo sapiens (human) | | 0.0044 |
SRSF protein kinase 3 | Homo sapiens (human) | | 1.77 |
Serine/threonine-protein kinase ICK | Homo sapiens (human) | | 0.0443 |
Aurora kinase C | Homo sapiens (human) | | 0.0022 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | | 0.0024 |
Protein kinase C theta type | Rattus norvegicus (Norway rat) | | 0.274 |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | | 0.3701 |
Serine/threonine-protein kinase 38-like | Homo sapiens (human) | | 0.0012 |
Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | | 0.1541 |
Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | | 0.0335 |
Serine/threonine-protein kinase WNK2 | Homo sapiens (human) | | 1.455 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | | 0.0017 |
5'-AMP-activated protein kinase subunit beta-1 | Homo sapiens (human) | | 1.1354 |
Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | | 0.0027 |
Serine/threonine-protein kinase 24 | Homo sapiens (human) | | 0.0065 |
Casein kinase I isoform gamma-3 | Homo sapiens (human) | | 2.675 |
Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0003 |
Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0013 |
Authors | Studies |
Atteridge, CE; Azimioara, MD; Benedetti, MG; Biggs, WH; Carter, TA; Ciceri, P; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Galvin, M; Gerlach, JL; Grotzfeld, RM; Herrgard, S; Insko, DE; Insko, MA; Lai, AG; Lélias, JM; Lockhart, DJ; Mehta, SA; Milanov, ZV; Patel, HK; Treiber, DK; Velasco, AM; Wodicka, LM; Zarrinkar, PP | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Russu, WA; Shallal, HM | 1 |
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Al-Mazaideh, GM; Erdmann, F; Göllner, C; Rohe, A; Schmidt, M; Sippl, W; Wichapong, K | 1 |
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
Creanor, J; Flatman, PW | 1 |
Koppal, T; Lukas, TJ; Mirzoeva, S; Petrova, TV; Van Eldik, LJ; Watterson, DM | 1 |
Behrens, MM; Choi, DW; Gwag, BJ; Koh, JY; Strasser, U | 1 |
Sharp, PA; Tang, H | 1 |
Kato, K; Kawamura, H; Kozawa, O; Matsui, N; Matsuno, H; Niwa, M; Otsuka, T; Uematsu, T | 1 |
Chen, CC; Chen, JJ; Chou, CY | 1 |
Lynn, EG; O, K; Slow, YL; Sung, FL; Wang, G | 1 |
Fong, WF; Lam, W; Leung, CH; Wong, NS; Yang, MS; Zhuang, WJ | 1 |
Hatakeyama, D; Ito, H; Kato, K; Kozawa, O; Matsui, N; Matsuno, H; Niwa, M; Otsuka, T; Uematsu, T | 1 |
Inaguma, Y; Ito, H; Iwamoto, I; Kato, K; Lida, K | 1 |
Kato, K; Kozawa, O; Matsuno, H; Niwa, M; Tokuda, H; Uematsu, T | 1 |
Gimbrone, MA; Masuda, J; Ochi, H | 1 |
Ho, YS; Lee, WS; Liang, YC; Lin, SY; Pan, S; Tsai, SH | 1 |
Grewal, S; Morrison, EE; Ponnambalam, S; Walker, JH | 1 |
Chain, BM; Cho, JY; Katz, DR | 1 |
Agrawal, DK; DelCore, MG; Hunter, WJ; Krueger, KD | 1 |
Andreka, P; Bishopric, NH; Evans, WH; Haywood, GA; Martin, PE; Turner, MS; Webster, KA; You, L | 1 |
Albrecht, A; Dehner, F; Greim, C; Herweh, Y; Laufer, S; Peifer, C; Thuma, S | 1 |
Ferjan, I; Stempelj, M | 1 |
Castedo, M; Criollo, A; Galluzzi, L; Kroemer, G; Senovilla, L; Vitale, I; Vivet, S | 1 |
Havlicek, L; Hyun, TK; Roitsch, T; Strnad, M | 1 |
Choi, HR; Kang, HT; Kim, SY; Park, SC; Ryu, SJ | 1 |
Guemez-Gamboa, A; Morán, J; Ramiro-Cortés, Y | 1 |
Kayamori, T; Miyamoto, A; Murayama, C; Shimizu, T | 1 |
Hasegawa, Y; Okada, Y; Shimizu, T; Takahashi, N | 1 |
Abbès, S; Aljanadi, O; Bissinger, R; Bouguerra, G; Lang, F | 1 |
Bissinger, R; Lang, F; Mack, AF; Peter, T; Signoretto, E | 1 |
Al Mamun Bhuyan, A; Bissinger, R; Lang, F; Signoretto, E | 1 |
Egler, J; Lang, F | 1 |
Al Mamun Bhuyan, A; Cao, H; Lang, F | 1 |
Article | Year |
A small molecule-kinase interaction map for clinical kinase inhibitors.Nature biotechnology, 2005, Volume: 23, Issue:3
Topics: Benzamides; Drug Design; Escherichia coli; Escherichia coli Proteins; Imatinib Mesylate; Microchemistry; Pharmaceutical Preparations; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Pyrimidines | 2005 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
A quantitative analysis of kinase inhibitor selectivity.Nature biotechnology, 2008, Volume: 26, Issue:1
Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship | 2008 |
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.European journal of medicinal chemistry, 2011, Volume: 46, Issue:6
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Comprehensive analysis of kinase inhibitor selectivity.Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.European journal of medicinal chemistry, 2013, Volume: 61Topics: Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glycolipids; Humans; Membrane Proteins; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Stimulation of Na+-K+-2Cl- cotransport by arsenite in ferret erythrocytes.The Journal of physiology, 1999, Aug-15, Volume: 519 Pt 1Topics: Animals; Arsenites; Bumetanide; Calcimycin; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Chlorides; Edetic Acid; Enzyme Inhibitors; Erythrocytes; Ferrets; Flavonoids; Genistein; Homeostasis; Imidazoles; In Vitro Techniques; Models, Biological; Potassium; Pyridines; Rubidium; Rubidium Radioisotopes; Sodium; Sodium-Potassium-Chloride Symporters; Staurosporine | 1999 |
Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets.Brain research, 1999, Oct-09, Volume: 844, Issue:1-2
Topics: Amidines; Animals; Benzylamines; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Line; Cell Nucleus; Cyclic AMP Response Element-Binding Protein; Drug Design; Enzyme Inhibitors; Flavonoids; Imidazoles; Indole Alkaloids; Isoquinolines; Lipopolysaccharides; Mice; Microglia; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Phosphorylation; Pyridines; Staurosporine; Sulfonamides | 1999 |
Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase.Neuroscience, 1999, Volume: 94, Issue:3
Topics: Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Culture Media, Serum-Free; Cycloheximide; Enzyme Inhibitors; Flavonoids; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetics; Maleimides; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Neurons; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phorbol Esters; Protein Kinase C; Pyridines; Staurosporine; Tetradecanoylphorbol Acetate | 1999 |
Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.Immunity, 1999, Volume: 11, Issue:5
Topics: 3' Untranslated Regions; Alleles; Animals; B-Lymphocytes; Cyclic AMP-Dependent Protein Kinases; DNA; DNA-Binding Proteins; Enhancer Elements, Genetic; Enzyme Inhibitors; Gene Expression Regulation; Genistein; Imidazoles; Immunoglobulin Heavy Chains; Isoquinolines; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Octamer Transcription Factor-2; Phosphorylation; Protein Binding; Protein Kinase C; Protein Processing, Post-Translational; Protein Structure, Tertiary; Pyridines; Recombinant Fusion Proteins; Staurosporine; Structure-Activity Relationship; Sulfonamides; Trans-Activators; Transcription Factors; Transcriptional Activation; Transfection | 1999 |
Endothelin-1 stimulates heat shock protein 27 induction in osteoblasts: involvement of p38 MAP kinase.The American journal of physiology, 1999, Volume: 277, Issue:6
Topics: Animals; Antihypertensive Agents; Blotting, Northern; Carcinogens; Cells, Cultured; Endothelin-1; Enzyme Inhibitors; Estrenes; Flavonoids; Gene Expression Regulation, Enzymologic; Genistein; Heat-Shock Proteins; Imidazoles; Mice; Mitogen-Activated Protein Kinases; Naphthalenes; Oligopeptides; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phorbol Esters; Phosphodiesterase Inhibitors; Phosphorylation; Piperidines; Propranolol; Protein Kinase C; Pyridines; Pyrrolidinones; RNA, Messenger; Skull; Staurosporine | 1999 |
Protein kinase calpha but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1beta: involvement of sequential activation of tyrosine kinase,Molecular pharmacology, 2000, Volume: 58, Issue:6
Topics: Bridged-Ring Compounds; Cells, Cultured; Enzyme Inhibitors; Flavonoids; Fluorescent Antibody Technique; Gene Expression; Humans; I-kappa B Kinase; Imidazoles; Indoles; Intercellular Adhesion Molecule-1; Interleukin-1; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Naphthalenes; NF-kappaB-Inducing Kinase; Norbornanes; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Kinase C-alpha; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Staurosporine; Thiocarbamates; Thiones; Tyrphostins | 2000 |
Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis.Molecular and cellular biochemistry, 2001, Volume: 216, Issue:1-2
Topics: Activating Transcription Factor 2; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Chemokine CCL2; Chemotaxis; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; ets-Domain Protein Elk-1; Homocysteine; Humans; Imidazoles; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monocytes; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyridines; RNA, Messenger; Staurosporine; Time Factors; Transcription Factors; Umbilical Veins | 2001 |
PKCdelta-dependent deubiquitination and stabilization of Gadd45 in A431 cells overexposed to EGF.Biochemical and biophysical research communications, 2001, Jul-13, Volume: 285, Issue:2
Topics: Acetophenones; Benzopyrans; Cell Division; Cycloheximide; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flavonoids; GADD45 Proteins; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Isoenzymes; Kinetics; Leupeptins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Proteins; Pyridines; Recombinant Proteins; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Ubiquitins | 2001 |
Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts.Cellular signalling, 2001, Volume: 13, Issue:8
Topics: Animals; Cell Line; Enzyme Inhibitors; Flavonoids; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Naphthalenes; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin D2; Pyridines; RNA, Messenger; Staurosporine | 2001 |
Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27.Cell stress & chaperones, 2001, Volume: 6, Issue:1
Topics: Anisomycin; Arsenites; Butadienes; Cadmium Chloride; Carcinogens; Dithiothreitol; Enzyme Inhibitors; Flavonoids; Glioma; Heat-Shock Proteins; Humans; Hydrogen Peroxide; Imidazoles; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; Osmotic Pressure; Oxidants; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Sodium Compounds; Sorbitol; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2001 |
Mechanism of prostaglandin E2-stimulated heat shock protein 27 induction in osteoblast-like MC3T3-E1 cells.The Journal of endocrinology, 2002, Volume: 172, Issue:2
Topics: Analysis of Variance; Animals; Butadienes; Calcium; Calcium Channel Blockers; Cell Line; Chelating Agents; Dinoprostone; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Estrenes; Flavonoids; Gallic Acid; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Imidazoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Molecular Chaperones; Naphthalenes; Neoplasm Proteins; Nitriles; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Pyridines; Pyrrolidinones; Staurosporine; Stimulation, Chemical; Time Factors; Type C Phospholipases | 2002 |
Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity.European journal of immunology, 2002, Volume: 32, Issue:7
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Cell Membrane; Cells, Cultured; Culture Media; Cycloheximide; DNA-Binding Proteins; E-Selectin; Endothelium, Vascular; Gene Expression Regulation; GTP-Binding Proteins; Imidazoles; Intercellular Adhesion Molecule-1; Interferon Regulatory Factor-1; Interferon-gamma; Interferon-Stimulated Gene Factor 3; Interleukin-1; Interleukin-13; Interleukin-4; NF-kappa B; Okadaic Acid; Osmosis; Phosphoproteins; Promoter Regions, Genetic; Pyridines; RNA, Messenger; Staurosporine; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2002 |
Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.Molecular carcinogenesis, 2002, Volume: 35, Issue:1
Topics: Adenocarcinoma; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Chromosome Mapping; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Disease Progression; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Serine-Threonine Kinases; Protein Transport; Pyridines; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Up-Regulation | 2002 |
Nuclear localisation of cytosolic phospholipase A2-alpha in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation.Journal of cell science, 2002, Dec-01, Volume: 115, Issue:Pt 23
Topics: Amino Acid Sequence; Cell Count; Cell Division; Cell Line; Cell Nucleus; Cytosol; Fatty Acids, Unsaturated; Flavonoids; Gene Expression Regulation, Enzymologic; Group IV Phospholipases A2; Humans; Imidazoles; Lectins; Models, Molecular; Molecular Sequence Data; Okadaic Acid; Phospholipases A; Phospholipases A2; Phosphorylation; Protein Conformation; Protein Transport; Pyridines; Staurosporine | 2002 |
Staurosporine induces rapid homotypic intercellular adhesion of U937 cells via multiple kinase activation.British journal of pharmacology, 2003, Volume: 140, Issue:2
Topics: Acetophenones; Adenosine Triphosphate; Benzopyrans; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; CD18 Antigens; Cell Aggregation; Cycloheximide; Cytoskeleton; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Genistein; Humans; Imidazoles; Indoles; Integrin beta1; Isoenzymes; Maleimides; Mitogen-Activated Protein Kinases; Naphthalenes; Phosphorylation; Phosphotransferases; Protein Kinase C; Protein-Tyrosine Kinases; Pyridines; Staurosporine; Temperature; Tetradecanoylphorbol Acetate; Time Factors; Tyrosine; U937 Cells | 2003 |
Calphostin C as a rapid and strong inducer of apoptosis in human coronary artery smooth muscle cells.International immunopharmacology, 2003, Volume: 3, Issue:13-14
Topics: Androstadienes; Animals; Apoptosis; Cells, Cultured; Chromones; Coronary Vessels; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Flavonoids; Humans; Imidazoles; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Microscopy, Electron, Scanning; Microscopy, Video; Mitogen-Activated Protein Kinases; Morpholines; Muscle, Smooth, Vascular; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Staurosporine; Time Factors; Wortmannin | 2003 |
Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.Circulation research, 2004, Oct-01, Volume: 95, Issue:7
Topics: Adenosine Triphosphate; Alkaloids; Aminoimidazole Carboxamide; Animals; Antimycin A; Benzophenanthridines; Brefeldin A; Carbazoles; Cell Hypoxia; Cells, Cultured; Connexin 43; Cycloheximide; Deoxyglucose; Flavonoids; Imidazoles; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Myocardial Contraction; Myocytes, Cardiac; Okadaic Acid; Ouabain; Phenanthridines; Phosphorylation; Potassium Cyanide; Protein Processing, Post-Translational; Pyridines; Pyrroles; Rats; Recombinant Fusion Proteins; Ribonucleotides; Staurosporine; Tacrolimus; Tetradecanoylphorbol Acetate | 2004 |
An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays.Analytical biochemistry, 2005, Sep-01, Volume: 344, Issue:1
Topics: Activating Transcription Factor 2; Enzyme Inhibitors; Imidazoles; Immunosorbent Techniques; Inhibitory Concentration 50; p38 Mitogen-Activated Protein Kinases; Pyridines; Staurosporine | 2005 |
Signaling pathway in nerve growth factor induced histamine release from rat mast cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2005, Volume: 54, Issue:8
Topics: Analysis of Variance; Androstadienes; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Flavonoids; Histamine; Imidazoles; Indoles; Male; Maleimides; Mast Cells; Models, Biological; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Kinase C; Pyridines; Pyrrolidinones; Rats; Rats, Wistar; Signal Transduction; Staurosporine; Tyrosine; Wortmannin | 2005 |
Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells.Cell cycle (Georgetown, Tex.), 2008, Jul-01, Volume: 7, Issue:13
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Checkpoint Kinase 1; Down-Regulation; Enzyme Inhibitors; HCT116 Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polyploidy; Protein Kinase Inhibitors; Protein Kinases; Pyridines; RNA, Small Interfering; Staurosporine; Transfection; Tumor Suppressor Protein p53 | 2008 |
Trisubstituted purines are useful tools for developing potent plant mitogen-activated protein kinase inhibitors.Bioscience, biotechnology, and biochemistry, 2010, Volume: 74, Issue:3
Topics: Benzyl Compounds; Cells, Cultured; Imidazoles; Kinetin; Mitogen-Activated Protein Kinases; Plants; Protein Kinase Inhibitors; Purines; Pyridines; Signal Transduction; Solanaceae; Staurosporine; Structure-Activity Relationship | 2010 |
Defective nuclear translocation of stress-activated signaling in senescent diploid human fibroblasts: a possible explanation for aging-associated apoptosis resistance.Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:8
Topics: Apoptosis; Cell Culture Techniques; Cell Survival; Cells, Cultured; Cellular Senescence; Child, Preschool; Diploidy; Fibroblasts; Flavonoids; Foreskin; Humans; Hydrogen Peroxide; Imidazoles; Interphase; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Pyridines; Staurosporine; Stress, Physiological; Wheat Germ Agglutinins | 2011 |
Reactive oxygen species participate in the p38-mediated apoptosis induced by potassium deprivation and staurosporine in cerebellar granule neurons.The international journal of biochemistry & cell biology, 2011, Volume: 43, Issue:9
Topics: Activating Transcription Factor 2; Animals; Antioxidants; Apoptosis; Caspases; Cerebellum; Enzyme Activation; Enzyme Assays; Imidazoles; Kaempferols; NADPH Oxidases; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Potassium; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Staurosporine | 2011 |
Bone morphogenetic protein (BMP)-4 and BMP-7 suppress granulosa cell apoptosis via different pathways: BMP-4 via PI3K/PDK-1/Akt and BMP-7 via PI3K/PDK-1/PKC.Biochemical and biophysical research communications, 2012, Jan-13, Volume: 417, Issue:2
Topics: Animals; Apoptosis; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein 7; Cattle; Cells, Cultured; Chromones; Enzyme Inhibitors; Female; Granulosa Cells; Humans; Imidazoles; Morpholines; Phosphatidylinositol 3-Kinases; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Staurosporine | 2012 |
The apoptotic volume decrease is an upstream event of MAP kinase activation during Staurosporine-induced apoptosis in HeLa cells.International journal of molecular sciences, 2012, Volume: 13, Issue:7
Topics: Anthracenes; Apoptosis; Caspase 3; Caspase 7; Cell Size; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; MAP Kinase Kinase 4; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyridines; Staurosporine | 2012 |
Embelin-Induced Phosphatidylserine Translocation in the Erythrocyte Cell Membrane.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 37, Issue:4
Topics: Aniline Compounds; Apoptosis; Benzoquinones; Calcium; Ceramides; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Imidazoles; Phosphatidylserines; Pyridines; Reactive Oxygen Species; Staurosporine; Xanthenes | 2015 |
Micafungin-Induced Suicidal Erythrocyte Death.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 39, Issue:2
Topics: Antifungal Agents; Benzamides; Calcium; Casein Kinase I; Cell Size; Ceramides; Echinocandins; Eryptosis; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Hemolysis; Humans; Imidazoles; Lipopeptides; Micafungin; Microscopy, Confocal; p38 Mitogen-Activated Protein Kinases; Phosphatidylserines; Protein Kinase C; Pyridines; Reactive Oxygen Species; Staurosporine | 2016 |
Stimulation of Suicidal Erythrocyte Death by Ceritinib-Treatment of Human Erythrocytes.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:5
Topics: Benzamides; Calcium; Cytosol; Eryptosis; Erythrocytes; Hemolysis; Humans; Imidazoles; Oligopeptides; Phosphatidylserines; Pyridines; Pyrimidines; Scattering, Radiation; Staurosporine; Sulfones | 2016 |
Triggering of Eryptosis, the Suicidal Erythrocyte Death, by Perifosine.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:6
Topics: Aniline Compounds; Calcium; Cell Size; Ceramides; Eryptosis; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Hemolysis; Humans; Imidazoles; Phosphatidylserines; Phosphorylcholine; Pyridines; Reactive Oxygen Species; Staurosporine; Xanthenes | 2017 |
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:4
Topics: Aniline Compounds; Annexin A5; Antineoplastic Agents; Benzamides; Benzophenanthridines; Calcium; Casein Kinase I; Caspases; Ceramides; Eryptosis; Erythrocytes; Fluoresceins; Gene Expression Regulation; Hemolysis; Humans; Imidazoles; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphatidylserines; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Reactive Oxygen Species; Signal Transduction; Sirolimus; Staurosporine; TOR Serine-Threonine Kinases; Xanthenes | 2017 |